What Does “250 mg/mL” Actually Prove? - Printable Version +- BodyTecHub (https://bodytechub.com) +-- Forum: Investigational/Steriods Finished Oil (https://bodytechub.com/forumdisplay.php?fid=4) +--- Forum: TEST C250 (https://bodytechub.com/forumdisplay.php?fid=23) +--- Thread: What Does “250 mg/mL” Actually Prove? (/showthread.php?tid=230)

What Does “250 mg/mL” Actually Prove? - BodyTecHub Editorial - 07-15-2026 A printed concentration is a manufacturer or seller claim. It is not an independent laboratory result. Known facts For an FDA-approved finished drug, the approval and manufacturing system applies to a specific product, facility, formulation and labeling. Unapproved drugs have not undergone FDA review for safety, effectiveness, quality or labeling. A seller’s COA may provide information about the sample tested, but it does not automatically prove that the sample came from the customer’s vial or that every vial in the batch is equivalent. Assay testing and identity testing answer different questions. A potency result also does not establish sterility, endotoxin control, particulate control, container integrity or correct storage. For any report to be interpretable, readers need the laboratory identity, sample ID, batch number, method, units, dates and chain of custody. What remains uncertain Without independent sampling, it may be impossible to know whether: The submitted sample came from the advertised batch The report was edited or reused The method was appropriate and validated The vial remained stable during shipping and storage Other units in the batch contain the same amount Microbiological and impurity risks were evaluated Injection discomfort or lack of discomfort is not a potency test. Questions for the community Can the report number be verified directly with the laboratory? Who selected, purchased and shipped the sample? Does the physical lot number match the report? Were identity, assay, impurities, sterility and endotoxin treated separately? Is the laboratory independent from the seller? What conclusion does the report support—and what does it not support? Sources FDA: Concerns about unapproved drugs — https://www.fda.gov/drugs/unapproved-drugs/fdas-concerns-about-unapproved-drugs FDA: Drug quality sampling and testing programs — https://www.fda.gov/drugs/science-and-research-drugs/drug-quality-sampling-and-testing-programs Safety note: This is an evidence-literacy discussion, not a product endorsement or sourcing thread. Last evidence review: July 15, 2026